We are live on
!
Find out more
MDSL
M.D. Sass LLC Portfolio holdings
AUM
$1.53B
1-Year Est. Return
30.78%
This Fund
S&P 500
This Quarter
Est. Return
-15.06%
1 Year Est. Return
+30.78%
3 Year Est. Return
+80.09%
5 Year Est. Return
+105.45%
10 Year Est. Return
+339.34%
AUM
$529M
AUM Growth
-$55.1M
(-9.4%)
Cap. Flow
+$30.3M
Cap. Flow
% of AUM
5.73%
Top 10 Holdings %
Top 10 Hldgs %
58.94%
Holding
37
New
6
Increased
14
Reduced
8
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MasTec
MTZ
|
+$28.9M |
| 2 |
FRC
First Republic Bank
FRC
|
+$28.3M |
| 3 |
Blue Owl Capital
OWL
|
+$25.1M |
| 4 |
Rockwell Automation
ROK
|
+$14.4M |
| 5 |
Liberty Media Series C
FWONK
|
+$9.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$31.5M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$25.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$18.5M |
| 4 |
Bausch Health
BHC
|
+$18.2M |
| 5 |
Quanta Services
PWR
|
+$9.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.31% |
| 2 | Industrials | 23.4% |
| 3 | Technology | 13.35% |
| 4 | Healthcare | 12.11% |
| 5 | Communication Services | 11.44% |
Similar funds
APCM
BWP
CCM
US
HCM
KCMH
KCM
MP
M.D. Sass LLC's Q2 2022 Portfolio in Review
As of Q2 2022, M.D. Sass LLC held 37 positions worth $529M, down 9.4% from $584M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
M.D. Sass LLC deployed $30.3M of net new capital in Q2 2022, opening 6 new positions and adding to 14 existing holdings. Its largest new stake was MasTec: 370,773 shares worth $26.6M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $18.5M trimmed.
- M.D. Sass LLC's largest Q2 2022 buy was MasTec: 370,773 shares worth $26.6M.
- M.D. Sass LLC added most to Liberty Media Series C in Q2 2022, an estimated $9.32M increase.
- M.D. Sass LLC's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $18.5M.
- M.D. Sass LLC fully exited Qorvo in Q2 2022, selling an estimated $31.5M.
- M.D. Sass LLC's ten largest holdings make up 59% of its $529M portfolio in Q2 2022.
- M.D. Sass LLC opened 6 new positions and closed 8 in Q2 2022.
- M.D. Sass LLC's portfolio value fell 9.4% quarter-over-quarter to $529M.
Based on M.D. Sass LLC's 13F filing for Q2 2022, filed 15 Aug 2022.